Effects of the fast of Ramadan on endothelial function and high-sensitivity C-reactive protein in newly diagnosed type 2 diabetic patients

Kuwait Medical Journal

Volumn 40, Issue 1, 2008, Pages 53-58

  Hamdy, Ehab A ^a,c,d   Attia, Shereen ^b   Ghonna, Reda ^c  

^a MINISTRY OF HEALTH   (Kuwait)

^b Department of Cardiology   (Kuwait)

^c ADAN HOSPITAL   (Kuwait)

^d TANTA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

C reactive protein; Endothelial dysfunction; High sensitivity; Ramadan Fasting; Waist circumference

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; ATHEROGENESIS; BRACHIAL ARTERY; CONTROLLED STUDY; DIET RESTRICTION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; KUWAIT; MAJOR CLINICAL STUDY; MALE; MOSLEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK REDUCTION; SENSITIVITY ANALYSIS; WAIST CIRCUMFERENCE;

EID: 69749116319     PISSN: 00235776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N. C- reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N EngI J Med 2000; 342:836-843.
3. Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in pmutaneous coronary intervention. Circulation 2001; 104: 992-997.
4. Pasceri V, Willerson JT, Yeh ET. Direct pro-inflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
5. Zwaka TP, Hombach V, Torzewski J. C- reactive protein - mediated low density lipoprotein uptake by macrophages: implication of atherosclerosis. Circulation 2001; 103: 1194-1197.
6. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102:1000-1006.
7. Yasojima K, Schwab C, McGeer EG, McGeer PL. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158:1039-1051.
8. Tomai F, Crea F, Gaspardone A, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation 2001; 104:1471-1476.
9. Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor - dependant monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20:2094-2099.
10. Verma S, Wang, CH, Li SH, et al. A self - fulfilling prophecy. C- reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106:913-919.
11. Ridker PM, Cushmen M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk bf cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979.
12. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein [a] and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285:2481-2485.
13. Van Der Meer JM, De Maat MP, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree. The Rotterdam Study. Stroke 2002; 33:2750-2755.
14. Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001; 104:63-67.
15. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C- reactive protein andlow density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557-1565.
16. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25:2016-2021.
17. Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105:23S-39S.
18. ManoT, Masuyama T, Yamamoto K, et al. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J 1996; 131:231-238.
19. Tooke JE. Micro-vascular function in human diabetes: a physiologic perspective. Diabetes 1995; 44:721-726.
20. Laurent S, Lacolley P, Brunel P, Laloux B, Pannier B, Safar M. Flow-dependent vasodilatation of bronchial artery in essential hypertension. Am J Physiol 1990; 258:1004-1011.
21. Anderson EA, Mark AL. Flow mediated and reflex changes in large peripheral artery tone in humans. Circulation 1989; 79:93-100.
22. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
23. Sorensen KE, Celermajer DS, Spiegelhalter DJ, et al. Noninvasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Rgart J 1993; 74:247-253.
24. Schaochinger V, Britten MB, Zeiber AM. Prognostic impact of coronary vasodilator dysfunction on adverse long term outcome of coronary heart disease. Circulation 2000; 101:1899-1906.
25. Nesto R. CHD: a major burden in type 2 diabetes. Acta Diabetol 2001; 38:S 3-9.
26. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial - dependent flow-mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Task Force. J Am Coll Cardiol 2002; 39:257-265.
27. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 2002; 287:356-359.
28. Ridker PM. High -sensitivity C- reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103:1813-1818.
29. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric-oxide mediated vasodilatation in patients with non-insulin dependant diabetes mellitus. J Am Coll Cardiol 1996; 27:567-574.
30. Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule and impaired microvascular reactivity and early markers of vasculopathy in type 2 diabetic individuals without micro-albuminuria. Diabetes Care 1999; 22:1865-1870.
31. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes: 1999; 48:1856-1862.
32. Hamdy O, Ledbury S, Mullooly C, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003; 26:2119-2125.
33. Soliman N. Effect of fasting during Ramadan. JJsl Med Assn 1987; 11:111-115.
34. Azizi F. Effect of dietary composition on fasting induced changes in serum thyroid hormones and thyrotropin. Metabolism 1978; 27:935-942.
35. Takruri HR. Effect of fasting in Ramadan on body weight. Saudi Med J 1989; 10: 491-494.
36. el Ati J, Beii C, Danguir J. Increased fat oxidation during Ramadan in healthy women: an adaptive mechanism for body weight maintenance. Am J Clin Nutr 1995; 62:302-07.
37. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and Tthe risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-733.
38. Ridker PM, Rifat N, Pfeffer MA, Sacks F, Braunwald E. Long term effects of pravastatin on,plasma concentration of C-reactive protein: the Cholesierol And Recurrent Events [CARE] Investigators. Circulation 1999; 100:230-235.